Outset Tablo Could Boost Use of Home Hemodialysis
In data from a survey of 202 dialysis patients presented at the NKF Spring Clinicals meeting in Boston, MA, 77% said the features of the Tablo would make them more likely to try home HD. In addition, 77% of 184 nephrologist agreed that the Tablo features were “a significant improvement”—and 98% said they would be more likely to recommend home HD to their patients.
Read the full article » | Posted 05-12-2022
Related Articles
- Baxter ASN Presence, 2018 Posted 10-05-2026
- Fresenius Kidney Care Reports PD Breakthroughs Posted 10-05-2026
- NIH to Consolidate Websites Under Nine Hubs Posted 09-18-2026
- FDA Warns Fresenius About Leaking PD Solution Bags and Particulates Posted 09-18-2026

